High transalveolar cycling pressures are often developed in order to bring sufficient fresh gas into contact with the capillary blood to satisfy ventilatory demands or therapeutic targets. An elevated breathing workload, high ventilating pressures, and alveolar overdistension are characteristic of status asthmaticus and acute exacerbations of chronic airflow obstruction. Certain lung units may also experience overinflation during the conventional management of the acute respiratory distress syndrome (ARDS). It is now understood that fewer than one third of all alveoli may remain accessible to gas during acute lung injury,' and that the stretching forces developed in achieving normocapnia with this reduced capacity may cause further damage or retard healing.2" Such knowledge has inspired various innovative approaches for accomplishing ventilation during critical illness, whose ultimate value remains unproven. Among these the technique of using smaller tidal volumes and "permissive hypercapnia" is perhaps the simplest and most widely applied. During tracheal gas insufflation-assisted ventilation Paco2 falls in a direct but non-linear relation to the rate of catheter flow.'929 Modest flows of fresh gas achieve nearly maximal benefit, as expected for a washout effect in a confined volume. Although flushing of the dead space proximal to the catheter orifice is undoubtedly the primary mechanism of action for tracheal gas insufflation, a jet of fresh catheter gas projects for a variable distance beyond the catheter orifice itself, extending the flushed region and improving distal gas mixing. This projection may explain why a straight catheter directed toward the main carina performs more effectively than one with an inverted tip whose orifice lies in the same transverse plane within the airway but points (mouthward) in the opposite direction.29 Non-bulk flow mechanisms of accomplishing alveolar gas exchange seem less important at the jet velocities achieved with the flows and catheter diameters generally used in experimental studies. Although catheters placed closer to the main carina perform somewhat better than those more proximal, the site of gas injection only moderately affects the efficiency of tracheal gas insufflation-aided ventila-pan expiratory injection of catheter gas is equally as effective as continuous tracheal gas insufflation, provided inspiratory tidal volumes are equivalent and identical volumes of fresh gas enter the trachea during the expiratory period.2930 Preserving the full ventilatory benefit of tracheal gas insufflation without the need for catheter flow during inspiration may be advantageous. High catheter flows may be required for optimal efficiency during the ventilation of certain patients with ARDS, especially when high ventilating frequencies or extended inspiratory time fractions limit the time available for expiratory flushing. The tracheal gas insufflation catheter effectively functions as a ventilator when the expiratory valve of the circuit is closed. Consequently continuous catheter flows may potentially increase the total inspired tidal volume and thereby lead to hyperinflation and violation of pressurelimiting guidelines unless an appropriate ventilator adjustment is made. (This is especially true during volume cycled ventilation when flows from ventilator and catheter are directly additive.) Catheter flow restricted to expiration, on the other hand, can be provided without risking end inspiratory overdistension or the need to restrict the flow range, provided that pressure controlled ventilation is used, or tidal volume is adjusted for any resulting auto-PEEP. Another advantage of using selective expiratory tracheal gas insufflation is that, unlike continuous tracheal gas insufflation, expiratory tracheal gas insufflation allows static conditions to be established during interruption of inspiratory flow. The pressure recorded during an end inspiratory pause therefore continues to reflect the average end inspiratory alveolar ("plateau") pressure (the sum of PEEP, auto-PEEP, and the quotient of tidal volume and respiratory system compliance).
Any "auto-PEEP" caused by tracheal gas insufflation may present either a problem or a therapeutic option. Even a phasic expiratory jet may raise mean alveolar pressure by directly opposing lung deflation, as well as by generating a back pressure across the endotracheal tube and expiration valve. Both effects are functions of catheter flow rate. Reducing the resistance of the endotracheal tube and expiratory valve are, therefore, the key to limiting the pressure which opposes lung deflation.
Because tracheal gas insufflation tends to raise end expiratory and mean alveolar pressures, it may improve arterial oxygenation in patients with parenchymal lung injury. An increase in mean alveolar pressure occurs routinely when continuous tracheal gas insufflation is added to an unchanging tidal volume delivered by the ventilator. Augmentation of end expiratory lung volume and mean alveolar pressure also occur, however, during selective expiratory injection. Such a mechanism may improve oxygenation in patients with acute lung injury.
Certain safety issues must be resolved before tracheal gas insufflation can be accepted for routine clinical use. Important questions relate to the need to humidify catheter gas and to address the purely technical problem of providing a pressure relief mechanism to stop catheter flow in the event of sudden endotracheal tube occlusion.
Furthermore, it is uncertain whether tracheal damage might result from an intense or prolonged catheter jeteven one restricted to the expiratory phase. Finally, an intraluminal catheter interferes with expiratory flow and with the elimination of airway secretions. The possibilities of extraluminal catheter placement or of injecting gas through channels embedded in the walls of an endotracheal tube specially constructed for this purpose are therefore especially interesting.
Although some work has been done in chronically ill patients with diseased airways,13-152627 the application of tracheal gas insufflation to critically ill patients with severe airflow obstruction has been very limited. Its effects may well vary with the type of obstruction under treatment. As already noted, the existence of a high alveolar dead space fraction tends to limit the effectiveness of tracheal gas insufflation, while hypercapnia tends to improve it. Therefore, for the patient with chronic bronchitis whose lung parenchyma is relatively normal, whose airways are intrinsically obstructed, and who retains carbon dioxide, tracheal gas insufflation would appear to be a particularly attractive option. For patients with emphysema, whose abnormal parenchyma produces high alveolar dead space and whose airways are functionally compressed, the benefit is less clear.
Other effects of tracheal gas insufflation on dyspnoea and the work of breathing have yet to be explored, especially in patients with airflow obstruction. Dynamic hyperinflation resulting from the flow retarding effects of tracheal gas insufflation could conceivably interfere with ventilator triggering or cause functional weakening of the inspiratory musculature. Alternatively, in the setting of tidal flow limitation, the flow retarding effects of tracheal gas insufflation could prove inconsequential. It Patients who have neuromuscular weakness as the primary cause of ventilatory failure are good candidates to benefit from tracheal gas insufflation. In these patients small tidal volumes, carbon dioxide retention, and dyspnoea typically result from a disproportion between workload and work capacity. The lung parenchyma often remains relatively normal. Conceptually, at least, the relatively large contribution of the proximal airway to the total physiological dead space fraction should boost the effectiveness of tracheal gas insufflation. Improved carbon dioxide elimination without the need to increase ventilation pressure allows the spontaneously breathing patient to reduce Paco2, limit total ventilatory effort, or both.
Tracheal gas insufflation has clear potential to improve the management of acute lung injury by reducing pressure requirements or by constraining the level of hypercapnia or the pace of its development. It is also a promising technique for certain forms of airflow obstruction and neuromuscular weakness, and could also conceivably facilitate ventilator weaning. Yet until the questions regarding its safety and efficacy are resolved and its operational characteristics are better defined, the clinical use of tracheal gas insufflation should be considered experimental. 
